Infab Acquires International Biomedical’s Glove Division

Infab LLC is bolstering its product offering with the purchase of International Biomedical Ltd.’s glove division. Neither company disclosed the deal’s terms.

“This acquisition is a very logical fit with Infab as it adds a radiation protection product of exceptional quality to our offering,” said Daren Dickerson, CEO of Infab. “The Infab team is very excited to add these gloves to our production so that we can be more responsive in providing critical products to healthcare professionals.”

The gloves are designed to reduce the amount of radiation exposure during surgical procedures.  
 
“John Segars, CEO of International Biomedical, has done a remarkable job building the glove business. We are very pleased to bring this excellent product line to leading healthcare customers worldwide,“ said Kent Robinson, HKW partner and Infab board chairman. “HKW’s emphasis on partnering in the health and wellness industry remains a key area of focus; this add-on strengthens our commitment to support the professionals within this sector.
 
Infab is a portfolio company of HKW that designs and builds lightweight, comfortable, and technologically advanced radiation protection products. Infab’s PPE products enable health care providers and patients to benefit from the diagnostic capabilities of imaging technology, functioning as a “one-stop-shop” for distributors and customers. 
 
HKW is a private equity firm investing in growth-oriented companies with talented management teams in the United States and Canada. HKW targets companies in the technology, health and wellness, and business services sectors. Since 1982, HKW has sponsored 66 platform transactions of lower middle-market companies throughout North America and 72 add-on acquisitions.